ReLink, a revolutionary device designed to enhance patient safety in IV therapy and nephrostomy care, has achieved a significant milestone by obtaining patent approval in Canada. This marks another step forward in ReLink's mission to transform healthcare through innovation and safety.
This new patent reinforces ReLink’s growing portfolio, enabling its life-saving technology to reach more hospitals and clinics worldwide. The device is already making a tangible difference by preventing catheter dislodgement, swiftly reinstating IV therapy or nephrostomy drainage, and empowering healthcare professionals to deliver reliable care.
"We’re proud to add this Canadian patent to our achievements. It’s a testament to the hard work of our incredible team and the support of our partners," said a company representative.
With this milestone, ReLink is set to make an even greater impact in the global healthcare community.
תגובות